Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.

This study has been terminated.

( closed due to toxicity )

Study NCT00565227 Information provided by University of Michigan Cancer Center

First Received: November 27, 2007 Last Updated: January 14, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	September 2009
Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)